US Health Department moves to reclassify marijuana as a lower-risk drug
3 min read
US Health Department moves to ease restrictions on marijuana by reclassifying it as a lower-risk drug
US Health Department moves to ease restrictions on marijuana by reclassifying it as a lower-risk drug.
The U.S. Department of Health and Human Services (HHS) has recommended easing restrictions on marijuana, a department spokesperson said on Wednesday, following a review request from the Biden Administration last year.
Nearly 40 U.S. states have legalized marijuana use in some form, but it remains completely illegal in some states and at the federal level.
Reclassifying marijuana as less harmful than drugs like heroin would be a first step toward wider legalization, a move backed by a majority of Americans.
The scheduling recommendation for marijuana was provided to the Drug Enforcement Agency (DEA) on Tuesday as part of President Biden’s directive to HHS, the spokesperson said.
“As part of this process, HHS conducted a scientific and medical evaluation for consideration by DEA. DEA has the final authority to schedule or reschedule a drug under the Controlled Substances Act. DEA will now initiate its review,” a DEA spokesperson said.
Marijuana is currently classified as a Schedule I drug under the Controlled Substances Act, meaning it has a high potential for abuse and no accepted medical use, along with drugs like heroin and LSD.
Kenya staring at fuel shortage as oil marketers blame it on EPRA
Why Ruto fired contractors on a roadside rally
Ruto reiterates ‘journey to heaven’ as one party withdraws from Mumias case after threats
List of issues agreed by Azimio and Kenya Kwanza to be discussed in the bipartisan talks
Ousted Ali Bongo begs for help as EU calls for a crisis meeting over Gabon coup (VIDEO)
HHS is recommending reclassifying marijuana to say it has a moderate to low potential for dependence and a lower abuse potential, which would put it in a class with ketamine and testosterone.
If marijuana classification were to ease at the federal level, that could allow major stock exchanges to list businesses that are in the cannabis trade, and potentially allow foreign companies to begin selling their products in the United States.
“The administration’s process is an independent process led by HHS, led by the Department of Justice and guided by evidence… we will let that process move forward,” White House Press Secretary Karine Jean-Pierre said.
Cannabis is legal in Canada, which has become the home in North America for publicly traded cannabis growers and distributors, many of which would be expected to expand into the United States if federal legalization follows there.
“For far too long, cannabis prohibition and its outdated status as a Schedule I substance have unduly harmed countless individuals affected by the failed War on Drugs,” Veranos CEO George Archos said.
Also read,
US investors respond on Kenya’s weakening shilling (Ksh)
Concerns over missing details on Ksh 13b World Bank loan
Gabon coup leaders name General Brice Oligui Nguema, cousin to Bongo as new leader
Wagner chief Prigozhin secretly buried without fanfare in public cemetery
Follow us
